A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
Clinical trial NCT07054190 · RECRUITING
Trial details
- NCT number
- NCT07054190
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2027-07-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.